Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples